SI1505965T1 - Use of the metabolite of valsartan to inhibit platelet aggregation - Google Patents

Use of the metabolite of valsartan to inhibit platelet aggregation

Info

Publication number
SI1505965T1
SI1505965T1 SI200330502T SI200330502T SI1505965T1 SI 1505965 T1 SI1505965 T1 SI 1505965T1 SI 200330502 T SI200330502 T SI 200330502T SI 200330502 T SI200330502 T SI 200330502T SI 1505965 T1 SI1505965 T1 SI 1505965T1
Authority
SI
Slovenia
Prior art keywords
valsartan
metabolite
platelet aggregation
inhibit platelet
inhibit
Prior art date
Application number
SI200330502T
Other languages
Slovenian (sl)
Inventor
Alex Malinin
Victor L Serebruany
Randy Lee Webb
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Priority claimed from PCT/EP2003/004997 external-priority patent/WO2003094915A1/en
Publication of SI1505965T1 publication Critical patent/SI1505965T1/en

Links

SI200330502T 2002-05-14 2003-05-13 Use of the metabolite of valsartan to inhibit platelet aggregation SI1505965T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38037302P 2002-05-14 2002-05-14
US39501402P 2002-07-11 2002-07-11
PCT/EP2003/004997 WO2003094915A1 (en) 2002-05-14 2003-05-13 Use of valsartan ot its metabolite to inhibit platelet aggregation
EP03749892A EP1505965B1 (en) 2002-05-14 2003-05-13 Use of the metabolite of valsartan to inhibit platelet aggregation

Publications (1)

Publication Number Publication Date
SI1505965T1 true SI1505965T1 (en) 2007-02-28

Family

ID=37775072

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330502T SI1505965T1 (en) 2002-05-14 2003-05-13 Use of the metabolite of valsartan to inhibit platelet aggregation

Country Status (1)

Country Link
SI (1) SI1505965T1 (en)

Similar Documents

Publication Publication Date Title
HK1139681A1 (en) Salts of valsartan
GB2403312B (en) Storage device that is connected to external storage
IL160180A0 (en) Model optimization of structure with additional materials
IL187528A0 (en) Use of pyrimidine compounds in the manufacture of medicaments
AU2003213606A8 (en) Mp53s as modifiers of the p53 pathway and methods of use
IL176932A0 (en) Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
HK1092078A1 (en) Methods of inhibiting the adherence of lenses to their packaging materials
ZA200407609B (en) Use of vitamin d compounds
GB0307671D0 (en) Improvements relating to the construction of playing surfaces
EP1757282A4 (en) The use of kauranes compounds in the manufacture of medicament
SI1505965T1 (en) Use of the metabolite of valsartan to inhibit platelet aggregation
AU2003223702A1 (en) Inhibition of platelet aggregation
EP1653011A4 (en) Revoling-frame structure of construction machinery
GB0312844D0 (en) Use of compounds in medicine
PL378711A1 (en) Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
AU2003274911A8 (en) Mrbs as modifiers of the rb pathway and methods of use
GB0328994D0 (en) Producing mementoes through the use of holograms
AU2003213662A8 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
AU2003294499A8 (en) Rhebs as modifiers of the rb pathway and methods of use
GB0302318D0 (en) Easy bag storer
AU2003217851A1 (en) MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
AU2003299990A1 (en) Mbcats as modifiers of the beta-catenin pathway and methods of use
TW580945U (en) Structure of 3-D assembled model
PL363724A1 (en) Modification to the design of roller-skates
GB0218043D0 (en) New use of diaza-anthracene compounds